Considering medicine adjustments in patients with renal impairment

1. Wang X, Tang J, Shen C, et al. Research progress of population pharmacokinetic of metformin. Biomed Res Int 2022;2022:4071111.

2. Kuan IHS, Wilson LC, Leishman JC, et al. Metformin doses to ensure efficacy and safety in patients with reduced kidney function. PLoS One 2021;16(2):e0246247.

3. Song A, Zhang C, Meng X. Mechanism and application of metformin in kidney diseases: An update. Biomed Pharmacother 2021;138:111454.

4. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010;2010(4):CD002967.

5. Kuan IHS, Savage RL, Duffull SB, et al. The association between metformin therapy and lactic acidosis. Drug Saf 2019;42(12):1449–69.

6. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 2022;102(5S):S1–127.

7. Colagiuri S, Matthews D, Leiter LA, et al. The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents. Diabetes Res Clin Pract 2018;143:1–14.

8. Courtois P, Sener A, Herbaut C, et al. Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects. Res Commun Mol Pathol Pharmacol 1999;103(2):211–22.

9. van Dalem J, Brouwers MC, Stehouwer CD, et al. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study. BMJ 2016;354:i3625.

10. Andersen SE, Christensen M. Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis. Br J Clin Pharmacol 2016;82(5):1291–302.

11. Teles F, Peçanha de Miranda Coelho JA, Albino RM, et al. Effectiveness of thiazide and thiazide-like diuretics in advanced chronic kidney disease: a systematic review and meta-analysis. Ren Fail 2023;45(1):2163903.

12. Pham NT, Owen JG, Singh N, Shaffi SK. The use of thiazide diuretics for the treatment of hypertension in patients with advanced chronic kidney disease. Cardiol Rev 2023;31(2):99–107.

13. Priamvada GS, Divyadarshini DS, Voora R. Use of thiazides to treat hypertension and advanced CKD. Curr Cardiol Rep 2022;24(12):2131–37.

14. New Zealand Society for the Study of Diabetes. Diabetes and driving. In: Type 2 Diabetes Management Guidelines. 2023.